Vision Achievement Limited’s Post

A privilege to be asked to deliver the keynote at The University of Edinburgh Advanced Care Research Centre symposium today - so many outstanding researchers and academics in the audience, it was a daunting prospect. But the invited topic lends itself to good discussion - how do we age well in a time of crisis? Many ways of looking at this, but creating the conditions to extend healthy life expectancy through a prevention agenda over the life course is the starting point. And creating sustainable and responsive health and care services when they’re needed is critical. Intervening upstream and delaying multimorbidity and frailty must be our goal. There’s a developing evidence base on what will work too. And by taking an approach that sees Realistic Medicine and Value Based Health and Care define how we support and work with people, we’re more likely to make this sustainable. Great discussion and questions afterwards have left me eager to hear more about what others are doing and how research and data can help inform our next steps.

TAKE THE CLINICIAN CHALLENGE https://lnkd.in/eZesMdTb. Watch presentations on www.Melody.education by Prof Michael Trauner Medical University of Vienna, Jörn M. Schattenberg University Medical Center Mainz and Meena Bansal Mount Sinai Health System. #MelodyEducation #NASH #NAFLD #CVD #fattyliver #liverdisease #liverfibrosis #NonAlcoholicLiverDisease #NonAlcoholicFattyLiverDisease #MASH #MASLD #Metabolicdysfunction–associatedsteatoticliverdisease #Metabolicdysfunction–associated steatohepatitis

TAKE THE CLINICIAN CHALLENGE https://lnkd.in/eZesMdTb. Watch presentations on www.Melody.education by Prof Michael Trauner Medical University of Vienna, Jörn M. Schattenberg University Medical Center Mainz and Meena Bansal Mount Sinai Health System. #MelodyEducation #NASH #NAFLD #CVD #fattyliver #liverdisease #liverfibrosis #NonAlcoholicLiverDisease #NonAlcoholicFattyLiverDisease #MASH #MASLD #Metabolicdysfunction–associatedsteatoticliverdisease #Metabolicdysfunction–associated steatohepatitis

Every year, millions in Europe experience heart attacks, and cardiac rehabilitation (CR) is vital for a faster and better #recovery. 🧡 Meet Ricardo, 81, from Santiago de Compostela, who has not only joined a CR program after his heart attack, but also joined the TIMELY EU Project trial, helping him with his recovery and overall health. Ricardo embraced the experience, eager to help science and monitor his progress. 📲 Want to read more about the project? Visit www.timely-project.com or follow them on LinkedIn ➡ TIMELY EU Project ⬅ for latest updates!

TAKE THE CLINICIAN CHALLENGE https://lnkd.in/eZesMdTb. Watch presentations on www.Melody.education by Prof Michael Trauner Medical University of Vienna, Jörn M. Schattenberg University Medical Center Mainz and Meena Bansal Mount Sinai Health System. #MelodyEducation #NASH #NAFLD #CVD #fattyliver #liverdisease #liverfibrosis #NonAlcoholicLiverDisease #NonAlcoholicFattyLiverDisease #MASH #MASLD #Metabolicdysfunction–associatedsteatoticliverdisease #Metabolicdysfunction–associated steatohepatitis

TAKE THE CLINICIAN CHALLENGE https://lnkd.in/eZesMdTb. Watch presentations on www.Melody.education by Prof Michael Trauner Medical University of Vienna, Jörn M. Schattenberg University Medical Center Mainz and Meena Bansal Mount Sinai Health System. #MelodyEducation #NASH #NAFLD #CVD #fattyliver #liverdisease #liverfibrosis #NonAlcoholicLiverDisease #NonAlcoholicFattyLiverDisease #MASH #MASLD #Metabolicdysfunction–associatedsteatoticliverdisease #Metabolicdysfunction–associated steatohepatitis

The health and life science economy is the region’s fastest growing industry sector! We stand out by… -out producing more graduate level students than peer and aspriational markets by total % -educating more than 500 graduate level students annually -providing more than $1 billion in GDP annually -growing the number of residents training in the region by more than 70 individuals over the past 10 years #talentevv #healthandlifesciences #economicdevelopment

While the collective memory of the COVID 19 pandemic may be waning, at FasterCures, we have been capturing lessons learned from the pandemic experience since 2020 that point toward opportunities to improve the biomedical research ecosystem for other health crises. We see tremendous opportunity to expand research collaborations, accelerate product development, embed real world data and evidence in regulatory review, speed clinical trial innovation, make clinical trials more accessible and importantly, ensure diverse racial and ethnic populations are represented in trials. Following up on the recommendations outlined in our January 2021 “Lessons Learned from COVID-19: Are There Silver Linings for Biomedical Innovation?” and the subsequent “Implementation Roadmap,” FasterCures released our newest report, “Protecting the Progress for Biomedical Innovation: A Post-Pandemic Scorecard.” How well are we doing on the lessons learned? From our engagement on the topics and interviews of 20 senior leaders in the field, we arrived at an overall grade of B-. While we uncovered a surprising number of positive developments, there remain significant impediments to protecting the progress that we saw during COVID-19.   Explore the scorecard for information about the overall grade of B- as well as grades and details across five broad areas including: research collaboration, acceleration of product development, clinical trial design and execution, collection and use of real-world data and evidence, and addressing racial and ethnic disparities in health care and research.   https://lnkd.in/egXZjTw7

#RareDiseaseWeek2024 starts today! Rare disease advocates from all over the country will travel to DC to share their stories, highlighting the urgent need for rare disease policy and research. Policy changes, advances in innovative therapies and personalized medicine, and shifting approaches to clinical research are converging to impact funding approaches for rare disease research potentially. Explore groundbreaking discussions from our #MIHealthSummit panel, focused on innovative funding models for rare disease research. Watch the panel here: https://lnkd.in/gNYmVnNQ. Let's drive progress at #RareDC24!